STAT

Opinion: Creating a Facebook for cell communication can help treat disease

Picture the immune system as a society of cells: diverse, interconnected, and dynamic, characterized by near-constant communication. Think Facebook, only at a greater magnitude and more complex.

Everyone, it seems, uses Facebook and LinkedIn these days. Social networking sites make it incredibly easy to find information about people. You can look up new acquaintances, professional contacts, even the author of this article to figure out who is worth connecting to and who might be trouble.

As a systems immunologist, I wish we had a Facebook for cells. Say you’ve encountered Dan in a tissue sample from a patient. He’s a and lives in the skin. Dan hangs out with Tess and Bess, from the lymphocyte group. Tess talks to Bess a lot, and every now and then gets her riled up. When this happens, the patient feels worse.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks